Á lódáil...
Development of thermosensitive resiquimod-loaded liposomes for enhanced cancer immunotherapy
Resiquimod (R848) is a toll-like receptor 7 and 8 (TLR7/8) agonist with potent antitumor and immunostimulatory activity. However, systemic delivery of R848 is poorly tolerated because of its poor solubility in water and systemic immune activation. In order to address these limitations, we developed...
Na minha lista:
| Foilsithe in: | J Control Release |
|---|---|
| Main Authors: | , , , , , , , , , , , , , , , |
| Formáid: | Artigo |
| Teanga: | Inglês |
| Foilsithe: |
2020
|
| Ábhair: | |
| Rochtain Ar Líne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7906914/ https://ncbi.nlm.nih.gov/pubmed/33189786 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jconrel.2020.11.013 |
| Clibeanna: |
Cuir Clib Leis
Gan Chlibeanna, Bí ar an gcéad duine leis an taifead seo a chlibeáil!
|